vimarsana.com

Page 17 - ச ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Parliamentarian asks was Interferon acquisition necessary?

defenceWeb Written by defenceWeb - Kobus Marais. A question Minister Nosiviwe Mapisa-Nqakula’s Heberon task team has to ask is how many COVID-19 infections and deaths are there in the SA National Defence Force (SANDF)? This, Democratic Alliance (DA) parliamentarian Kobus Marais believes, will be a valuable pointer as to whether the national defence force needed to acquire the Cuban drug to boost soldiers’ immune systems for additional protection while on Operation Notlela duty. He told defenceWeb questions on the number of infections and deaths were not responded to. “Working through the Joint Standing Committee on Defence (JSCD) brought the same outcome,” he said. defenceWeb experienced a similar response with questions to the SANDF Directorate: Corporate Communications going unanswered. A reliable source in the military indicated it was “quite possible” information on COVID-19 deaths and infections are treated as “battlefield intelligence” not for public consu

Fewer than half a million have received jabs in Sub-Saharan Africa so far

Local scientist s discovery gives Covid-19 testing a boost

Local scientist’s discovery gives Covid-19 testing a boost Share Johannesburg - South Africa has received a boost for its Covid-19 testing after local medical scientist Faith Koopa discovered a Covid-19 testing antigen. The antigen is part of Koopa’s rollout of 200 million coronavirus test kits across the country. The laboratories involved, Pathology LabOne, are the first of their kind in Khayelitsha in the Western Cape and Midstream, near Pretoria. The laboratories are also manned by women doctors and scientists. While 40 million coronavirus test kits have landed in South Africa from the US, the kits are a part of the 200 million ordered for a laboratory called Pathology LabOne from the US.

More light shed on Phase 2 of SA s vaccine rollout

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.